Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurie Wagner

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 6, 2022
Survival and epidemiology of amyotrophic lateral sclerosis (ALS) cases in the Chicago and Detroit metropolitan cohort: incident cases 2009-2011 and survival through 2018Reshma Punjani, Theodore C Larson, Laurie Wagner, et al.
Biopreservation and Biobanking|July 15, 2021
Analysis of Biospecimen Demand and Utilization of Samples from the National Amyotrophic Lateral Sclerosis BiorepositoryMarianna J Bledsoe, Lindsay Rechtman, Laurie Wagner, et al.
Texas Medicine|June 21, 2012
Prevalence of amyotrophic lateral sclerosis in Texas, 1998-2003Laurie Wagner, Natalie P Archer, Dhelia M Williamson, et al.
Preventing Chronic Disease|December 31, 2009
The prevalence of multiple sclerosis in 3 US communitiesCurtis W Noonan, Dhelia M Williamson, Judy P Henry, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 25, 2020
Keratinous biomarker of mercury exposure associated with amyotrophic lateral sclerosis risk in a nationwide U.S. studyAngeline S Andrew, Katie M O'Brien, Brian P Jackson, et al.
Neuroepidemiology|January 29, 2020
Feasibility of Using a Nationally Representative Telephone Survey to Monitor Multiple Sclerosis Prevalence in the United StatesStephen L Buka, Mitch T Wallin, William J Culpepper, et al.
Neurology|February 17, 2019
A new way to estimate neurologic disease prevalence in the United States: Illustrated with MSLorene M Nelson, Mitchell T Wallin, Ruth Ann Marrie, et al.
JAMA Neurology|May 15, 2023
Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic RegionMichael Hittle, William J Culpepper, Annette Langer-Gould, et al.
Neurology|February 17, 2019
Validation of an algorithm for identifying MS cases in administrative health claims datasetsWilliam J Culpepper, Ruth Ann Marrie, Annette Langer-Gould, et al.
Neurology|February 17, 2019
The prevalence of MS in the United States: A population-based estimate using health claims dataMitchell T Wallin, William J Culpepper, Jonathan D Campbell, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 6, 2022
Survival and epidemiology of amyotrophic lateral sclerosis (ALS) cases in the Chicago and Detroit metropolitan cohort: incident cases 2009-2011 and survival through 2018Reshma Punjani, Theodore C Larson, Laurie Wagner, et al.
Biopreservation and Biobanking|July 15, 2021
Analysis of Biospecimen Demand and Utilization of Samples from the National Amyotrophic Lateral Sclerosis BiorepositoryMarianna J Bledsoe, Lindsay Rechtman, Laurie Wagner, et al.
Texas Medicine|June 21, 2012
Prevalence of amyotrophic lateral sclerosis in Texas, 1998-2003Laurie Wagner, Natalie P Archer, Dhelia M Williamson, et al.
Preventing Chronic Disease|December 31, 2009
The prevalence of multiple sclerosis in 3 US communitiesCurtis W Noonan, Dhelia M Williamson, Judy P Henry, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 25, 2020
Keratinous biomarker of mercury exposure associated with amyotrophic lateral sclerosis risk in a nationwide U.S. studyAngeline S Andrew, Katie M O'Brien, Brian P Jackson, et al.
Neuroepidemiology|January 29, 2020
Feasibility of Using a Nationally Representative Telephone Survey to Monitor Multiple Sclerosis Prevalence in the United StatesStephen L Buka, Mitch T Wallin, William J Culpepper, et al.
Neurology|February 17, 2019
A new way to estimate neurologic disease prevalence in the United States: Illustrated with MSLorene M Nelson, Mitchell T Wallin, Ruth Ann Marrie, et al.
JAMA Neurology|May 15, 2023
Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic RegionMichael Hittle, William J Culpepper, Annette Langer-Gould, et al.
Neurology|February 17, 2019
Validation of an algorithm for identifying MS cases in administrative health claims datasetsWilliam J Culpepper, Ruth Ann Marrie, Annette Langer-Gould, et al.
Neurology|February 17, 2019
The prevalence of MS in the United States: A population-based estimate using health claims dataMitchell T Wallin, William J Culpepper, Jonathan D Campbell, et al.
Pageof 2